Impax Laboratories - Articles and news items

FDA approves ZOMIG Nasal Spray migraine treatment for use in the US in paediatric patients

Industry news / 17 June 2015 / Victoria White

The FDA has approved ZOMIG Nasal Spray for use in the US in paediatric patients 12 years of age and older for the treatment of migraine with or without aura…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+